You are here
AstraZeneca's COVID vaccine suffers a setback in nasal spray trial
Primary tabs
Tue, 2022-10-11 22:46 — mike kraft
AstraZeneca's COVID vaccine suffers a setback in nasal spray trial Attempts by Oxford University researchers and AstraZeneca Plc to create a nasal-spray version of their jointly developed COVID-19 shot suffered a setback on Tuesday as initial testing on humans did not yield the desired protection. Reuters
...
An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in the first of usually three phases of clinical testing, the University of Oxford said in a statement on Tuesday.
...
Country / Region Tags:
General Topic Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
- Private group -
Recent Comments